img

Global Glutamate Antagonist Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glutamate Antagonist Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glutamate Antagonists work by inhibiting the activity of glutamate receptors in the brain. These receptors are broadly classified into two main subtypesN-methyl-D-aspartate (NMDA) and 3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors.
Global Glutamate Antagonist market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
Glutamate antagonists are being investigated as potential treatments for various neurological and psychiatric disorders, including epilepsy, depression, anxiety disorders, neuropathic pain, and neurodegenerative diseases like Alzheimer's and Parkinson's. Some glutamate antagonists have been approved for use in treating epilepsy, particularly drug-resistant forms of the condition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glutamate Antagonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG
Segment by Type
Ionic
Non Ionic

Segment by Application


Hospitals
Clinics
Laboratory
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glutamate Antagonist market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glutamate Antagonist, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glutamate Antagonist industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glutamate Antagonist in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glutamate Antagonist introduction, etc. Glutamate Antagonist Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Glutamate Antagonist market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Glutamate Antagonist Market Overview
1.1 Glutamate Antagonist Product Overview
1.2 Glutamate Antagonist Market Segment by Type
1.2.1 Ionic
1.2.2 Non Ionic
1.3 Global Glutamate Antagonist Market Size by Type
1.3.1 Global Glutamate Antagonist Market Size Overview by Type (2018-2029)
1.3.2 Global Glutamate Antagonist Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glutamate Antagonist Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glutamate Antagonist Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glutamate Antagonist Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glutamate Antagonist Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glutamate Antagonist Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glutamate Antagonist Sales Breakdown by Type (2018-2024)
2 Global Glutamate Antagonist Market Competition by Company
2.1 Global Top Players by Glutamate Antagonist Sales (2018-2024)
2.2 Global Top Players by Glutamate Antagonist Revenue (2018-2024)
2.3 Global Top Players by Glutamate Antagonist Price (2018-2024)
2.4 Global Top Manufacturers Glutamate Antagonist Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glutamate Antagonist Market Competitive Situation and Trends
2.5.1 Glutamate Antagonist Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glutamate Antagonist Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glutamate Antagonist as of 2022)
2.7 Date of Key Manufacturers Enter into Glutamate Antagonist Market
2.8 Key Manufacturers Glutamate Antagonist Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glutamate Antagonist Status and Outlook by Region
3.1 Global Glutamate Antagonist Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Glutamate Antagonist Historic Market Size by Region
3.2.1 Global Glutamate Antagonist Sales in Volume by Region (2018-2024)
3.2.2 Global Glutamate Antagonist Sales in Value by Region (2018-2024)
3.2.3 Global Glutamate Antagonist Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glutamate Antagonist Forecasted Market Size by Region
3.3.1 Global Glutamate Antagonist Sales in Volume by Region (2024-2029)
3.3.2 Global Glutamate Antagonist Sales in Value by Region (2024-2029)
3.3.3 Global Glutamate Antagonist Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Glutamate Antagonist by Application
4.1 Glutamate Antagonist Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Laboratory
4.1.4 Others
4.2 Global Glutamate Antagonist Market Size by Application
4.2.1 Global Glutamate Antagonist Market Size Overview by Application (2018-2029)
4.2.2 Global Glutamate Antagonist Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glutamate Antagonist Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glutamate Antagonist Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glutamate Antagonist Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glutamate Antagonist Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glutamate Antagonist Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glutamate Antagonist Sales Breakdown by Application (2018-2024)
5 North America Glutamate Antagonist by Country
5.1 North America Glutamate Antagonist Historic Market Size by Country
5.1.1 North America Glutamate Antagonist Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Glutamate Antagonist Sales in Volume by Country (2018-2024)
5.1.3 North America Glutamate Antagonist Sales in Value by Country (2018-2024)
5.2 North America Glutamate Antagonist Forecasted Market Size by Country
5.2.1 North America Glutamate Antagonist Sales in Volume by Country (2024-2029)
5.2.2 North America Glutamate Antagonist Sales in Value by Country (2024-2029)
6 Europe Glutamate Antagonist by Country
6.1 Europe Glutamate Antagonist Historic Market Size by Country
6.1.1 Europe Glutamate Antagonist Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Glutamate Antagonist Sales in Volume by Country (2018-2024)
6.1.3 Europe Glutamate Antagonist Sales in Value by Country (2018-2024)
6.2 Europe Glutamate Antagonist Forecasted Market Size by Country
6.2.1 Europe Glutamate Antagonist Sales in Volume by Country (2024-2029)
6.2.2 Europe Glutamate Antagonist Sales in Value by Country (2024-2029)
7 Asia-Pacific Glutamate Antagonist by Region
7.1 Asia-Pacific Glutamate Antagonist Historic Market Size by Region
7.1.1 Asia-Pacific Glutamate Antagonist Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Glutamate Antagonist Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glutamate Antagonist Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glutamate Antagonist Forecasted Market Size by Region
7.2.1 Asia-Pacific Glutamate Antagonist Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Glutamate Antagonist Sales in Value by Region (2024-2029)
8 Latin America Glutamate Antagonist by Country
8.1 Latin America Glutamate Antagonist Historic Market Size by Country
8.1.1 Latin America Glutamate Antagonist Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Glutamate Antagonist Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glutamate Antagonist Sales in Value by Country (2018-2024)
8.2 Latin America Glutamate Antagonist Forecasted Market Size by Country
8.2.1 Latin America Glutamate Antagonist Sales in Volume by Country (2024-2029)
8.2.2 Latin America Glutamate Antagonist Sales in Value by Country (2024-2029)
9 Middle East and Africa Glutamate Antagonist by Country
9.1 Middle East and Africa Glutamate Antagonist Historic Market Size by Country
9.1.1 Middle East and Africa Glutamate Antagonist Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Glutamate Antagonist Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glutamate Antagonist Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glutamate Antagonist Forecasted Market Size by Country
9.2.1 Middle East and Africa Glutamate Antagonist Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Glutamate Antagonist Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Artemis Neuroscience
10.1.1 Artemis Neuroscience Company Information
10.1.2 Artemis Neuroscience Introduction and Business Overview
10.1.3 Artemis Neuroscience Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Artemis Neuroscience Glutamate Antagonist Products Offered
10.1.5 Artemis Neuroscience Recent Development
10.2 VistaGen Therapeutics
10.2.1 VistaGen Therapeutics Company Information
10.2.2 VistaGen Therapeutics Introduction and Business Overview
10.2.3 VistaGen Therapeutics Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.2.4 VistaGen Therapeutics Glutamate Antagonist Products Offered
10.2.5 VistaGen Therapeutics Recent Development
10.3 Rottapharm Madaus
10.3.1 Rottapharm Madaus Company Information
10.3.2 Rottapharm Madaus Introduction and Business Overview
10.3.3 Rottapharm Madaus Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Rottapharm Madaus Glutamate Antagonist Products Offered
10.3.5 Rottapharm Madaus Recent Development
10.4 Amorsa Therapeutics
10.4.1 Amorsa Therapeutics Company Information
10.4.2 Amorsa Therapeutics Introduction and Business Overview
10.4.3 Amorsa Therapeutics Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amorsa Therapeutics Glutamate Antagonist Products Offered
10.4.5 Amorsa Therapeutics Recent Development
10.5 Newron Pharmaceuticals
10.5.1 Newron Pharmaceuticals Company Information
10.5.2 Newron Pharmaceuticals Introduction and Business Overview
10.5.3 Newron Pharmaceuticals Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Newron Pharmaceuticals Glutamate Antagonist Products Offered
10.5.5 Newron Pharmaceuticals Recent Development
10.6 Purdue Biopharma
10.6.1 Purdue Biopharma Company Information
10.6.2 Purdue Biopharma Introduction and Business Overview
10.6.3 Purdue Biopharma Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Purdue Biopharma Glutamate Antagonist Products Offered
10.6.5 Purdue Biopharma Recent Development
10.7 Relmada Therapeutics
10.7.1 Relmada Therapeutics Company Information
10.7.2 Relmada Therapeutics Introduction and Business Overview
10.7.3 Relmada Therapeutics Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Relmada Therapeutics Glutamate Antagonist Products Offered
10.7.5 Relmada Therapeutics Recent Development
10.8 BioCrea GmbH
10.8.1 BioCrea GmbH Company Information
10.8.2 BioCrea GmbH Introduction and Business Overview
10.8.3 BioCrea GmbH Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.8.4 BioCrea GmbH Glutamate Antagonist Products Offered
10.8.5 BioCrea GmbH Recent Development
10.9 Cerecor Inc.
10.9.1 Cerecor Inc. Company Information
10.9.2 Cerecor Inc. Introduction and Business Overview
10.9.3 Cerecor Inc. Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Cerecor Inc. Glutamate Antagonist Products Offered
10.9.5 Cerecor Inc. Recent Development
10.10 NeurOp Inc.
10.10.1 NeurOp Inc. Company Information
10.10.2 NeurOp Inc. Introduction and Business Overview
10.10.3 NeurOp Inc. Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.10.4 NeurOp Inc. Glutamate Antagonist Products Offered
10.10.5 NeurOp Inc. Recent Development
10.11 UCB SA
10.11.1 UCB SA Company Information
10.11.2 UCB SA Introduction and Business Overview
10.11.3 UCB SA Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.11.4 UCB SA Glutamate Antagonist Products Offered
10.11.5 UCB SA Recent Development
10.12 Novartis AG
10.12.1 Novartis AG Company Information
10.12.2 Novartis AG Introduction and Business Overview
10.12.3 Novartis AG Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Novartis AG Glutamate Antagonist Products Offered
10.12.5 Novartis AG Recent Development
10.13 Luc Therapeutics Inc.
10.13.1 Luc Therapeutics Inc. Company Information
10.13.2 Luc Therapeutics Inc. Introduction and Business Overview
10.13.3 Luc Therapeutics Inc. Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Luc Therapeutics Inc. Glutamate Antagonist Products Offered
10.13.5 Luc Therapeutics Inc. Recent Development
10.14 Evotec AG
10.14.1 Evotec AG Company Information
10.14.2 Evotec AG Introduction and Business Overview
10.14.3 Evotec AG Glutamate Antagonist Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Evotec AG Glutamate Antagonist Products Offered
10.14.5 Evotec AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glutamate Antagonist Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glutamate Antagonist Industrial Chain Analysis
11.4 Glutamate Antagonist Market Dynamics
11.4.1 Glutamate Antagonist Industry Trends
11.4.2 Glutamate Antagonist Market Drivers
11.4.3 Glutamate Antagonist Market Challenges
11.4.4 Glutamate Antagonist Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glutamate Antagonist Distributors
12.3 Glutamate Antagonist Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ionic
Table 2. Major Company of Non Ionic
Table 3. Global Glutamate Antagonist Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 5. Global Glutamate Antagonist Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Glutamate Antagonist Sales by Type (2018-2024) & (US& Million)
Table 7. Global Glutamate Antagonist Market Share in Value by Type (2018-2024)
Table 8. Global Glutamate Antagonist Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 10. Global Glutamate Antagonist Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Glutamate Antagonist Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Glutamate Antagonist Sales Market Share in Value by Type (2024-2029)
Table 13. Global Glutamate Antagonist Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 15. North America Glutamate Antagonist Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Glutamate Antagonist Sales (K Units) by Type (2018-2024)
Table 17. Europe Glutamate Antagonist Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Glutamate Antagonist Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Glutamate Antagonist Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Glutamate Antagonist Sales (K Units) by Type (2018-2024)
Table 21. Latin America Glutamate Antagonist Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Glutamate Antagonist Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Glutamate Antagonist Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Glutamate Antagonist Sales by Company (2018-2024) & (K Units)
Table 25. Global Glutamate Antagonist Sales Share by Company (2018-2024)
Table 26. Global Glutamate Antagonist Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Glutamate Antagonist Revenue Share by Company (2018-2024)
Table 28. Global Market Glutamate Antagonist Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Glutamate Antagonist Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Glutamate Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glutamate Antagonist as of 2022)
Table 32. Date of Key Manufacturers Enter into Glutamate Antagonist Market
Table 33. Key Manufacturers Glutamate Antagonist Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Glutamate Antagonist Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Glutamate Antagonist Sales by Region (2018-2024) & (K Units)
Table 37. Global Glutamate Antagonist Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Glutamate Antagonist Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Glutamate Antagonist Sales Market Share in Value by Region (2018-2024)
Table 40. Global Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Glutamate Antagonist Sales by Region (2024-2029) & (K Units)
Table 42. Global Glutamate Antagonist Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Glutamate Antagonist Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Glutamate Antagonist Sales Market Share in Value by Region (2024-2029)
Table 45. Global Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Glutamate Antagonist Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 48. Global Glutamate Antagonist Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Glutamate Antagonist Sales Market Share in Value by Application (2018-2024)
Table 51. Global Glutamate Antagonist Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 53. Global Glutamate Antagonist Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Glutamate Antagonist Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Glutamate Antagonist Sales Market Share in Value by Application (2024-2029)
Table 56. Global Glutamate Antagonist Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Glutamate Antagonist Sales by Application (2018-2024) (K Units)
Table 58. North America Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Glutamate Antagonist Sales by Application (2018-2024) (K Units)
Table 60. Europe Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Glutamate Antagonist Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Glutamate Antagonist Sales by Application (2018-2024) (K Units)
Table 64. Latin America Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Glutamate Antagonist Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Glutamate Antagonist Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 68. North America Glutamate Antagonist Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Glutamate Antagonist Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Glutamate Antagonist Sales Market Share in Value by Country (2018-2024)
Table 71. North America Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 72. North America Glutamate Antagonist Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Glutamate Antagonist Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Glutamate Antagonist Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 76. Europe Glutamate Antagonist Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Glutamate Antagonist Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Glutamate Antagonist Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 80. Europe Glutamate Antagonist Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Glutamate Antagonist Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Glutamate Antagonist Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Glutamate Antagonist Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Glutamate Antagonist Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Glutamate Antagonist Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Glutamate Antagonist Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Glutamate Antagonist Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Glutamate Antagonist Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Glutamate Antagonist Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Glutamate Antagonist Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Glutamate Antagonist Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Glutamate Antagonist Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Glutamate Antagonist Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Glutamate Antagonist Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Glutamate Antagonist Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Glutamate Antagonist Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Glutamate Antagonist Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Glutamate Antagonist Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Glutamate Antagonist Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Glutamate Antagonist Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Glutamate Antagonist Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Glutamate Antagonist Sales Market Share in Value by Country (2024-2029)
Table 107. Artemis Neuroscience Company Information
Table 108. Artemis Neuroscience Introduction and Business Overview
Table 109. Artemis Neuroscience Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Artemis Neuroscience Glutamate Antagonist Product
Table 111. Artemis Neuroscience Recent Development
Table 112. VistaGen Therapeutics Company Information
Table 113. VistaGen Therapeutics Introduction and Business Overview
Table 114. VistaGen Therapeutics Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. VistaGen Therapeutics Glutamate Antagonist Product
Table 116. VistaGen Therapeutics Recent Development
Table 117. Rottapharm Madaus Company Information
Table 118. Rottapharm Madaus Introduction and Business Overview
Table 119. Rottapharm Madaus Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Rottapharm Madaus Glutamate Antagonist Product
Table 121. Rottapharm Madaus Recent Development
Table 122. Amorsa Therapeutics Company Information
Table 123. Amorsa Therapeutics Introduction and Business Overview
Table 124. Amorsa Therapeutics Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Amorsa Therapeutics Glutamate Antagonist Product
Table 126. Amorsa Therapeutics Recent Development
Table 127. Newron Pharmaceuticals Company Information
Table 128. Newron Pharmaceuticals Introduction and Business Overview
Table 129. Newron Pharmaceuticals Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Newron Pharmaceuticals Glutamate Antagonist Product
Table 131. Newron Pharmaceuticals Recent Development
Table 132. Purdue Biopharma Company Information
Table 133. Purdue Biopharma Introduction and Business Overview
Table 134. Purdue Biopharma Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Purdue Biopharma Glutamate Antagonist Product
Table 136. Purdue Biopharma Recent Development
Table 137. Relmada Therapeutics Company Information
Table 138. Relmada Therapeutics Introduction and Business Overview
Table 139. Relmada Therapeutics Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Relmada Therapeutics Glutamate Antagonist Product
Table 141. Relmada Therapeutics Recent Development
Table 142. BioCrea GmbH Company Information
Table 143. BioCrea GmbH Introduction and Business Overview
Table 144. BioCrea GmbH Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. BioCrea GmbH Glutamate Antagonist Product
Table 146. BioCrea GmbH Recent Development
Table 147. Cerecor Inc. Company Information
Table 148. Cerecor Inc. Introduction and Business Overview
Table 149. Cerecor Inc. Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Cerecor Inc. Glutamate Antagonist Product
Table 151. Cerecor Inc. Recent Development
Table 152. NeurOp Inc. Company Information
Table 153. NeurOp Inc. Introduction and Business Overview
Table 154. NeurOp Inc. Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. NeurOp Inc. Glutamate Antagonist Product
Table 156. NeurOp Inc. Recent Development
Table 157. UCB SA Company Information
Table 158. UCB SA Introduction and Business Overview
Table 159. UCB SA Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. UCB SA Glutamate Antagonist Product
Table 161. UCB SA Recent Development
Table 162. Novartis AG Company Information
Table 163. Novartis AG Introduction and Business Overview
Table 164. Novartis AG Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Novartis AG Glutamate Antagonist Product
Table 166. Novartis AG Recent Development
Table 167. Luc Therapeutics Inc. Company Information
Table 168. Luc Therapeutics Inc. Introduction and Business Overview
Table 169. Luc Therapeutics Inc. Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Luc Therapeutics Inc. Glutamate Antagonist Product
Table 171. Luc Therapeutics Inc. Recent Development
Table 172. Evotec AG Company Information
Table 173. Evotec AG Introduction and Business Overview
Table 174. Evotec AG Glutamate Antagonist Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Evotec AG Glutamate Antagonist Product
Table 176. Evotec AG Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Glutamate Antagonist Market Trends
Table 180. Glutamate Antagonist Market Drivers
Table 181. Glutamate Antagonist Market Challenges
Table 182. Glutamate Antagonist Market Restraints
Table 183. Glutamate Antagonist Distributors List
Table 184. Glutamate Antagonist Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Glutamate Antagonist Product Picture
Figure 2. Global Glutamate Antagonist Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Glutamate Antagonist Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Glutamate Antagonist Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Ionic
Figure 6. Global Ionic Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Non Ionic
Figure 8. Global Non Ionic Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Glutamate Antagonist Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Glutamate Antagonist Sales Market Share by Type in 2022 & 2029
Figure 11. North America Glutamate Antagonist Sales Market Share in Volume by Type in 2022
Figure 12. North America Glutamate Antagonist Sales Market Share in Value by Type in 2022
Figure 13. Europe Glutamate Antagonist Sales Market Share in Volume by Type in 2022
Figure 14. Europe Glutamate Antagonist Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Glutamate Antagonist Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Glutamate Antagonist Sales Market Share in Value by Type in 2022
Figure 17. Latin America Glutamate Antagonist Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Glutamate Antagonist Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Glutamate Antagonist Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Glutamate Antagonist Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Glutamate Antagonist Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Glutamate Antagonist Revenue in 2022
Figure 23. Glutamate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Laboratory
Figure 29. Global Laboratory Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Glutamate Antagonist Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Glutamate Antagonist Sales Market Share by Application in 2022 & 2029
Figure 34. North America Glutamate Antagonist Sales Market Share in Volume by Application in 2022
Figure 35. North America Glutamate Antagonist Sales Market Share in Value by Application in 2022
Figure 36. Europe Glutamate Antagonist Sales Market Share in Volume by Application in 2022
Figure 37. Europe Glutamate Antagonist Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Glutamate Antagonist Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Glutamate Antagonist Sales Market Share in Value by Application in 2022
Figure 40. Latin America Glutamate Antagonist Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Glutamate Antagonist Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Glutamate Antagonist Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Glutamate Antagonist Manufacturing Cost Structure
Figure 45. Glutamate Antagonist Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries